Clinical Trial Update: Sorafenib Tosylate and Stereotactic Radiosurgery in Treating Patients With Brain Metastases [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating sorafenib tosylate in combination with stereotactic radiosurgery for brain metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Sorafenib tosylate (sorafenib tosylate)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Tumors Metastatic to Brain | Phase 1 | Status: COMPLETED